GSK Sold Assets to Crown Laboratories

November 30, 2018

Overview

GlaxoSmithKline PLC (GSK) is a global pharmaceutical development, manufacturing, and marketing company. GSK sold five branded assets to Crown Laboratories a portfolio company of Hildred Capital Partners LLC. Financial terms of the transaction weren’t disclosed.

Significance

This transaction will provide Crown Laboratories with broader portfolio of differentiated branded product.

Crosstree’s Role

Crosstree served as sole advisor to GlaxoSmithKline PLC (GSK).

GSK Sold Assets to Crown Laboratories